Colonial Trust Advisors’s Cano Health, Inc. CANO Stock Holding History

Colonial Trust Advisors’s Portfolio CANO Stock Details CANO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-25	Closed	-$634	–	960
2023 Q3	$634	Hold	25	–	–	﹤0.01%	809
2023 Q2	$3.48K	Hold	25	–	–	﹤0.01%	680
2023 Q1	$2.27K	Hold	25	–	–	﹤0.01%	718
2022 Q4	$3.42K	Buy	+25	New	+$8.46K	﹤0.01%	661

Other funds holding CANO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCM

Connective Capital Management Palo Alto, California $121M AUM 39.82% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Colonial Trust Advisors's CANO Position: Q4 2023 in Review

Colonial Trust Advisors sold out of Cano Health, Inc. (CANO) in Q4 2023, closing a stake of 25 shares — an estimated $634 sold.

Colonial Trust Advisors first reported a position in CANO in Q4 2022 and held it in 4 quarters. The position peaked at $3.48K in Q2 2023. 50 funds tracked by Wall St. Rank hold CANO as of Q4 2023.

Colonial Trust Advisors reported no remaining Cano Health, Inc. position as of Q4 2023 after selling out during the quarter.
Colonial Trust Advisors sold 25 Cano Health, Inc. shares in Q4 2023, an estimated $634.
Colonial Trust Advisors first reported a position in Cano Health, Inc. in Q4 2022 and held it in 4 quarters.
Colonial Trust Advisors's Cano Health, Inc. position peaked at $3.48K in Q2 2023.
50 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q4 2023.

Based on Colonial Trust Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.